Adverse event Famitinib Famitinib Omeprazole Omeprazole Famitinib + Omeprazole Famitinib + Omeprazole Total Total
N=20 N=20 N=20 N=20 N=20 N=20 N=20 N=20
n(%) Incidence n(%) Incidence n(%) Incidence n(%) Incidence
Any treatment-emergent adverse event 6 (30.0%) 9 1 ( 5.0%) 1 5 (25.0%) 6 9 (45.0%) 16
Gamma-glutamyl transferase increased 0 0 0 0 1 ( 5.0%) 1 1 ( 5.0%) 1
Alanine aminotransferase increased 2 (10.0%) 2 0 0 0 0 2 (10.0%) 2
White blood cells urine positive 1 ( 5.0%) 1 0 0 0 0 1 ( 5.0%) 1
Glucose urine present 1 ( 5.0%) 1 0 0 0 0 1 ( 5.0%) 1
Basophil Count increased 1 ( 5.0%) 1 0 0 1 ( 5.0%) 1 1 ( 5.0%) 2
Heart rate increased 1 ( 5.0%) 1 0 0 1 ( 5.0%) 1 2 (10.0%) 2
Blood triglycerides increased 2 (10.0%) 2 0 0 0 0 2 (10.0%) 2
Blood glucose increased 1 ( 5.0%) 1 0 0 0 0 1 ( 5.0%) 1
Blood pressure decreased 0 0 1 ( 5.0%) 1 2 (10.0%) 3 2 (10.0%) 4